20 May 2013
Keywords: Canada, Rare diseases strategy, Orphan drugs, BIOTECanada, Rx&D
Article | 04 October 2012
The Canadian government this week announced a new national framework to improve access to “orphan drugs” for people ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 October 2012
17 May 2013
© 2013 thepharmaletter.com